Investigation on Behalf of Sage Therapeutics Investors by Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP, a prominent national securities litigation law firm, is probing potential claims against Sage Therapeutics, Inc. SAGE, which is based in Cambridge, Massachusetts and part of the biopharmaceutical industry specializing in the central nervous system disorders. The investigation focuses on whether the company and its executives breached federal securities laws.

Concerns for SAGE Shareholders

The law firm is looking into allegations that may affect investor interests, particularly examining potential misrepresentations by Sage Therapeutics. Investors are encouraged to contact James (Josh) Wilson, a partner at Faruqi & Faruqi, LLP, if they have experienced losses exceeding $75,000 by investing in Sage Therapeutics. Mr. Wilson is available to discuss possible legal remedies with Sage shareholders.

Legal Recourse for Investors

Shareholders who have suffered significant losses can reach out directly to Mr. Wilson to explore their legal rights and options. The call for shareholders comes in light of potential concerns regarding SAGE's business practices and financial disclosures. The investigation by Faruqi & Faruqi, LLP serves to determine whether the company's leadership has engaged in any actions that would be contrary to the investors' interests and possibly resulting in financial losses.

Investigation, Securities, Legal